PARIS (AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion, ending months of corporate haggling....
genzymeSanofi-Aventis to buy Genzyme for $20.1 bln cashHeadlines from the Associated Press Wed, 02/16/2011 - 03:45
FDA finds bits of steel, rubber in Genzyme drugsHeadlines from the Associated Press Fri, 11/13/2009 - 15:23
WASHINGTON (AP) -- Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues.... |
